Incubator funds promising biotech research & spins out
Investors 1
| Date | Name | Website |
| - | K2X | k2x.capita... |
Mentions in press and media 4
| Date | Title | Description |
| 27.02.2012 | A new migraine drug taken by skin? How Achelios could make it happen | “We’re still in the preclinical stage,” Frangakis said. “We hope to be in the clinic soon.” The name Achelios plays on the name “Achelois.” The Greek goddess’ name loosely translates as “she who washes away pain.” The company Achelios did n... |
| 21.11.2011 | Exodos targets pain drug market with topical NSAID; expects mid-2012 IND | ELS115 is being developed with technology licensed from San Diego, California biotechnology company Apricus Biosciences (NASDAQ:APRI). Apricus’ technology platform NexACT improves the delivery of the active drug with the addition of nonacti... |
| - | A new migraine drug taken by skin? How Achelios could make it happen | A new migraine treatment from pharmaceutical startup Achelios Therapeutics could enter clinical trials later this year, and it will be a new take on an older pain drug. The Chapel Hill, North Carolina company has raised $1.8 million out of ... |
| - | Exodos targets pain drug market with topical NSAID; expects mid-2012 IND | Topical nonsteroidal anti-inflammatory drugs have been limited by the difficulty of getting an active ingredient to effectively penetrate the skin. Chapel Hill, North Carolina pharmaceutical company Exodos Life Sciences aims to break that b... |